Prehabilitation of complex ventral hernia patients with Botulinum : a systematic review of the quantifiable effects of Botulinum
© 2020. Springer-Verlag France SAS, part of Springer Nature..
PURPOSE: Complex ventral hernia repair (CVHR) encompasses patient optimization, primary fascial closure (PFC), mesh reinforcement and component separation technique (CST), if needed. High rates of complications after CST are still reported. Prehabilitation by managing pre-operative modifiable risk factors, like abdominal wall compliance, possibly reduces these rates. Compliance can be modified by intramuscular injection of Botulinum in the lateral abdominal wall muscles (LAWM). Paralysis leads to elongation of these muscles, which may facilitate PFC and/or prevent CST. Evidence to use Botulinum in hernia patients is scarce and fragmented. An update of evidence for the effect of Botulinum is presented.
METHODS: A multi-database search was conducted for Botulinum studies in ventral hernia patients. A systematic review was performed to describe its primary effect on compliance (LAWM elongation) and secondary effects like PFC ± CST rate, complications and recurrence.
RESULTS: 14 studies were included (377 patients) with a HDW of median 12 (10-15) cm. A typical intervention consisted of 200-300 U Botulinum in 3 points per hemi-abdomen under US guidance, > 2 weeks pre-operatively and evaluated by CT just before the operation. The primary effect was a median LAWM elongation of 4.0 cm per side without complications of the injection (four studies, 107 patients). The median PFC rate was 100%, CST rate 38%, wound-related complications 19%, medical complications 18% and recurrence 0% (14 studies).
CONCLUSION: Botulinum safely elongates the abdominal wall muscles, but the level of evidence available remains low. Any patient in whom PFC is expected to be difficult, could be a candidate for prehabilitation with Botulinum.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Hernia : the journal of hernias and abdominal wall surgery - 25(2021), 6 vom: 19. Dez., Seite 1427-1442 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wegdam, J A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Abdominal wall compliance |
|---|
| Anmerkungen: |
Date Completed 08.04.2022 Date Revised 28.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10029-020-02333-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317823280 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317823280 | ||
| 003 | DE-627 | ||
| 005 | 20231225164054.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10029-020-02333-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1059.xml |
| 035 | |a (DE-627)NLM317823280 | ||
| 035 | |a (NLM)33215244 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wegdam, J A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prehabilitation of complex ventral hernia patients with Botulinum |b a systematic review of the quantifiable effects of Botulinum |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.04.2022 | ||
| 500 | |a Date Revised 28.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020. Springer-Verlag France SAS, part of Springer Nature. | ||
| 520 | |a PURPOSE: Complex ventral hernia repair (CVHR) encompasses patient optimization, primary fascial closure (PFC), mesh reinforcement and component separation technique (CST), if needed. High rates of complications after CST are still reported. Prehabilitation by managing pre-operative modifiable risk factors, like abdominal wall compliance, possibly reduces these rates. Compliance can be modified by intramuscular injection of Botulinum in the lateral abdominal wall muscles (LAWM). Paralysis leads to elongation of these muscles, which may facilitate PFC and/or prevent CST. Evidence to use Botulinum in hernia patients is scarce and fragmented. An update of evidence for the effect of Botulinum is presented | ||
| 520 | |a METHODS: A multi-database search was conducted for Botulinum studies in ventral hernia patients. A systematic review was performed to describe its primary effect on compliance (LAWM elongation) and secondary effects like PFC ± CST rate, complications and recurrence | ||
| 520 | |a RESULTS: 14 studies were included (377 patients) with a HDW of median 12 (10-15) cm. A typical intervention consisted of 200-300 U Botulinum in 3 points per hemi-abdomen under US guidance, > 2 weeks pre-operatively and evaluated by CT just before the operation. The primary effect was a median LAWM elongation of 4.0 cm per side without complications of the injection (four studies, 107 patients). The median PFC rate was 100%, CST rate 38%, wound-related complications 19%, medical complications 18% and recurrence 0% (14 studies) | ||
| 520 | |a CONCLUSION: Botulinum safely elongates the abdominal wall muscles, but the level of evidence available remains low. Any patient in whom PFC is expected to be difficult, could be a candidate for prehabilitation with Botulinum | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Abdominal wall compliance | |
| 650 | 4 | |a Botulinum | |
| 650 | 4 | |a Complex ventral hernia repair | |
| 650 | 4 | |a Complications | |
| 650 | 4 | |a Prehabilitation | |
| 650 | 7 | |a Neuromuscular Agents |2 NLM | |
| 650 | 7 | |a Botulinum Toxins, Type A |2 NLM | |
| 650 | 7 | |a EC 3.4.24.69 |2 NLM | |
| 700 | 1 | |a de Vries Reilingh, T S |e verfasserin |4 aut | |
| 700 | 1 | |a Bouvy, N D |e verfasserin |4 aut | |
| 700 | 1 | |a Nienhuijs, S W |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hernia : the journal of hernias and abdominal wall surgery |d 1998 |g 25(2021), 6 vom: 19. Dez., Seite 1427-1442 |w (DE-627)NLM09654385X |x 1248-9204 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2021 |g number:6 |g day:19 |g month:12 |g pages:1427-1442 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10029-020-02333-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2021 |e 6 |b 19 |c 12 |h 1427-1442 | ||